Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 1.00 |
| ▸ | SOAT1 | P35610 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.89 |
| ▸ | CNR1 | P21554 | 1/20 | 0.78 |
| ▸ | TERT | O14746 | 3/20 | 0.70 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.70 |
| ▸ | PPARG | P37231 | 3/20 | 0.70 |
| ▸ | PPARD | Q03181 | 3/20 | 0.70 |
| ▸ | PPARA | Q07869 | 3/20 | 0.70 |
| ▸ | MAPT | P10636 | 2/20 | 0.70 |
| ▸ | BLM | P54132 | 2/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.70 |
| ▸ | FABP4 | P15090 | 2/20 | 0.70 |
| ▸ | GMNN | O75496 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oleamide SCHEMBL7650473 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL11846101 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| Oleamide SCHEMBL195221 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL21983255 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL23528231 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL10445392 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL24340776 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL21501560 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL21654359 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL22419041 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1771206-B1 | LIPIDS, LIPID COMPLEXES AND USE THEREOF | SILENCE THERAPEUTICS GMBH (DE) | 2018-04-11 | — | — | EP | disclosed |
| US-20170036990-A1 | LIPIDS, LIPID COMPLEXES AND USE THEREOF | SILENCE THERAPEUTICS AG (DE) | 2017-02-09 | — | — | US | disclosed |
| US-9486538-B2 | Lipids, lipid complexes and use thereof | SILENCE THERAPEUTICS GMBH (DE) | 2016-11-08 | — | — | US | disclosed |
| US-9387262-B2 | Coated lipid complexes and their use | SILENCE THERAPEUTICS GMBH (DE) | 2016-07-12 | — | — | US | disclosed |
| EP-2992902-A1 | LIPID COMPLEXES COATED WITH PEG AND THEIR USES | Silence Therapeutics GmbH (DE) | 2016-03-09 | — | — | EP | disclosed |
| CN-102940891-B | Lipid, lipid complex and application thereof | SILENCE THERAPEUTICS AG (DE) | 2016-02-24 | — | — | CN | disclosed |
| US-20150359906-A1 | LIPIDS, LIPID COMPLEXES AND USE THEREOF | SILENCE THERAPEUTICS AG (DE) | 2015-12-17 | — | — | US | disclosed |
| US-9125820-B2 | Lipids, lipid complexes and use thereof | SILENCE THERAPEUTICS GMBH (DE) | 2015-09-08 | — | — | US | disclosed |
| EP-1830888-B1 | LIPID COMPLEXES COATED WITH PEG AND THEIR USE | SILENCE THERAPEUTICS GMBH (DE) | 2015-08-05 | — | — | EP | disclosed |
| US-20150031752-A1 | COATED LIPID COMPLEXES AND THEIR USE | SILENCE THERAPEUTICS AG (DE) | 2015-01-29 | — | — | US | disclosed |
| US-20120065138-A1 | LIPIDS, LIPID COMPLEXES AND USE THEREOF | SILENCE THERAPEUTICS AG (DE) | 2012-03-15 | — | — | US | disclosed |
| US-20110294871-A1 | LIPIDS, LIPID COMPLEXES AND USE THEREOF | SILENCE THERAPEUTICS AG (DE) | 2011-12-01 | — | — | US | disclosed |
| US-8017804-B2 | Lipids, lipid complexes and use thereof | SILENCE THERAPEUTICS AG (DE) | 2011-09-13 | — | — | US | disclosed |
| US-20100062967-A1 | COATED LIPID COMPLEXES AND THEIR USE | SILENCE THERAPEUTICS AG (DE) | 2010-03-11 | — | — | US | disclosed |
| WO-2006069782-A9 | LIPID COMPLEXES COATED WITH PEG AND THEIR USE | SILENCE THERAPEUTICS AG (DE) | 2009-04-30 | — | — | WO | disclosed |
| US-20080274116-A1 | Lipids, Lipid Complexes and Use Thereof | SILENCE THERAPEUTICS AG (DE) | 2008-11-06 | — | — | US | disclosed |
| EP-1830888-A2 | LIPID COMPLEXES COATED WITH PEG AND THEIR USE | Silence Therapeutics AG (DE) | 2007-09-12 | — | — | EP | disclosed |
| EP-1771206-A2 | LIPIDS, LIPID COMPLEXES AND USE THEREOF | atugen AG (DE) | 2007-04-11 | — | — | EP | disclosed |
| WO-2006069782-A2 | LIPID COMPLEXES COATED WITH PEG AND THEIR USE | SILENCE THERAPEUTICS AG. (DE) | 2006-07-06 | — | — | WO | disclosed |
| WO-2005105152-A2 | LIPIDS, LIPID COMPLEXES AND USE THEREOF | ATUGEN AG (DE) | 2005-11-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120065138-A1 | LIPIDS, LIPID COMPLEXES AND USE THEREOF | MGLL, LIPA, SGMS1 | FAAH 167/4885SOAT1 82/4885CYP1A2 856/4885 |
| US-20110294871-A1 | LIPIDS, LIPID COMPLEXES AND USE THEREOF | MGLL, LIPA, SGMS1 | FAAH 167/4885SOAT1 82/4885CYP1A2 856/4885 |
| US-20100062967-A1 | COATED LIPID COMPLEXES AND THEIR USE | HDLBP, NR1H3, CETP | FAAH 313/4885SOAT1 63/4885CYP1A2 2920/4885 |
| US-20170036990-A1 | LIPIDS, LIPID COMPLEXES AND USE THEREOF | MGLL, LIPA, LIPC | FAAH 185/4885SOAT1 107/4885CYP1A2 718/4885 |
| US-20150359906-A1 | LIPIDS, LIPID COMPLEXES AND USE THEREOF | MGLL, LIPA, LIPC | FAAH 185/4885SOAT1 107/4885CYP1A2 718/4885 |
| US-20150031752-A1 | COATED LIPID COMPLEXES AND THEIR USE | HDLBP, NR1H3, CETP | FAAH 313/4885SOAT1 63/4885CYP1A2 2920/4885 |
| US-20080274116-A1 | Lipids, Lipid Complexes and Use Thereof | MGLL, LIPA, SGMS1 | FAAH 153/4885SOAT1 79/4885CYP1A2 771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.